Get the Stockscreener App
0.6108
0.15%
-0.0016
Tilray Brands Inc stock is traded at $0.6108, with a volume of 7.67M.
It is down -0.15% in the last 24 hours and up +47.56% over the past month.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
See More
Previous Close:
$0.6124
Open:
$0.616
24h Volume:
7.67M
Relative Volume:
0.25
Market Cap:
$617.06M
Revenue:
$829.22M
Net Income/Loss:
$-248.96M
P/E Ratio:
-2.036
EPS:
-0.3
Net Cash Flow:
$-92.10M
1W Performance:
-12.99%
1M Performance:
+47.56%
6M Performance:
-41.76%
1Y Performance:
-69.88%
1-Day Range:
$0.598
$0.6347
1-Week Range:
$0.551
$0.71
52-Week Range:
$0.3507
$2.11
Tilray Brands Inc Stock (TLRY) Company Profile
Name
Tilray Brands Inc
Sector
Phone
519.322.8800
Address
655 MADISON AVENUE, NEW YORK
Compare TLRY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
0.6115 | 618.01M | 829.22M | -248.96M | -92.10M | -0.30 |
|
ZTS
Zoetis Inc
|
147.99 | 67.23B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.68 | 45.23B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.515 | 44.07B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.36 | 18.97B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
132.44 | 13.28B | 2.41B | 305.80M | 492.20M | 2.95 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-05-24 | Reiterated | Alliance Global Partners | Neutral |
| Nov-02-22 | Initiated | Bernstein | Mkt Perform |
| Jul-29-22 | Downgrade | The Benchmark Company | Hold → Sell |
| Mar-04-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Nov-18-21 | Initiated | Barclays | Underweight |
| Nov-01-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-11-21 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-03-21 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| May-11-21 | Resumed | Cowen | Outperform |
| May-07-21 | Resumed | Jefferies | Buy |
| May-06-21 | Initiated | Canaccord Genuity | Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-18-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-18-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Nov-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Nov-11-20 | Downgrade | Stifel | Hold → Sell |
| Oct-01-20 | Reiterated | MKM Partners | Neutral |
| Sep-21-20 | Upgrade | Jefferies | Underperform → Hold |
| May-12-20 | Reiterated | The Benchmark Company | Buy |
| Apr-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Apr-09-20 | Downgrade | Consumer Edge Research | Overweight → Equal Weight |
| Feb-24-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-13-20 | Initiated | BofA/Merrill | Neutral |
| Nov-13-19 | Reiterated | The Benchmark Company | Buy |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-22-19 | Reiterated | Piper Jaffray | Overweight |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Aug-14-19 | Reiterated | The Benchmark Company | Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Neutral |
| Jun-28-19 | Initiated | Consumer Edge Research | Overweight |
| Jun-06-19 | Initiated | Stifel | Hold |
| Jun-05-19 | Initiated | Oppenheimer | Perform |
| May-15-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| May-13-19 | Initiated | Alliance Global Partners | Neutral |
View All
Tilray Brands Inc Stock (TLRY) Latest News
Atb Cap Markets Forecasts Tilray Brands Q4 Earnings - MarketBeat
FY2026 EPS Estimates for Tilray Brands Increased by Analyst - MarketBeat
Is Tilray Brands a Dirt Cheap Growth Stock or Just a Bad Buy? - AOL.com
2 Surging Stocks That You'll Want to Think Twice About Buying Today - Yahoo Finance
What are Tilray Brands Inc. company’s key revenue driversBeginner Investor Guidance For 2025 - jammulinksnews.com
Irwin D. Simon Buys 165,000 Shares of Tilray Brands, Inc. (NASDAQ:TLRY) Stock - MarketBeat
Tilray brands CEO Simon Irwin D buys $100k in shares - Investing.com
Tilray Brands Executives Make Significant Stock Purchases - TradingView
Carl A. Merton Acquires 33,500 Shares of Tilray Brands, Inc. (NASDAQ:TLRY) Stock - MarketBeat
Tilray Brands (NASDAQ:TLRY) Posts Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
Tilray Brands (NASDAQ:TLRY) Trading Up 5.4%Here's Why - MarketBeat
Tilray Beverage Biz Posts $241M in Revenue for FY25; Company Records $1.4B Non-Cash Impairment - Brewbound
Tilray Brands, Inc. (NASDAQ:TLRY) Q4 2025 Earnings Call Transcript - Insider Monkey
Tilray Brands Full Year 2025 Earnings: Misses Expectations - Yahoo Finance
Tilray Stock (TLRY): Q4 Results Weigh on Future Prospects - Value The Markets
Tilray Brands 2025 Q4 Earnings Mixed Results as Net Income Declines 8146.5% - AInvest
Tilray Brands Reports In-Line Q4-2025 And FY2025 Results Amidst Weakening Sector - Seeking Alpha
Tilray Brands shares rise 1.04% after-hours following Q4 2025 earnings call. - AInvest
Earnings live: Starbucks posts another US sales decline, Novo stock plunges, Big Tech giants on deck - Yahoo Finance
Tilray Brands (NASDAQ:TLRY) Shares Down 11.8%What's Next? - MarketBeat
Why Tilray Stock Burned Out Today - MSN
Why Tilray Stock Burned Out Today - The Motley Fool
Tilray Brands (NASDAQ:TLRY) Shares Gap DownHere's What Happened - MarketBeat
Tilray sends pot stocks lower after Q4 results - MSN
Tilray Earnings: Strategic Moves Offer Some Help to Challenged Cannabis, but Alcohol Struggles - Morningstar
Tilray sends pot stocks lower after Q4 results (TLRY:NASDAQ) - Seeking Alpha
Following Mixed Q4 Results, Tilray's Turnaround Strategy Is Put To The Test - Benzinga
Earnings live: Spotify, Novo, UnitedHealth stocks slide after results; Boeing beats - Yahoo Finance
Tilray Plummets With $1.27B Q4 Net Loss Due To 2021 Aphria Merger - thedeepdive.ca
Tilray Brands, Inc. (NASDAQ:TLRY) Receives $1.92 Consensus PT from Brokerages - MarketBeat
Cannabis Pharmaceuticals Market Report 2025-2029 and 2034 Featuring Leading PlayersCuraleaf, Aphria, Green Thumb Industries, Trulieve Cannabis Corp, and Tilray - Yahoo Finance
Tilray Brands (NASDAQ:TLRY) Earns Neutral Rating from Zelman & Associates - MarketBeat
Tilray Brands Plunges 10.86% on Mixed Earnings - AInvest
Earnings live: Whirlpool, Tilray stocks tumble, with Spotify earnings on deck - Yahoo Finance
Tilray Brands, Inc. SEC 10-K Report - TradingView
Biggest stock movers Tuesday: TLRY, PHG, and more (NYSE:PHG) - Seeking Alpha
Order Book Volume Tilts Bullish on Tilray Brands Inc.Risk Adjusted Technical Entry Plan Gains Followers - metal.it
Tilray Brands (TSE:TLRY) Trading Up 1.1%Still a Buy? - MarketBeat
Tilray Brands Inc (TLRY) Q4 2025 Earnings Call Highlights: Record International Cannabis ... - Yahoo Finance
Tilray Brands Reports Growth in Cannabis and Beverage Segments - TipRanks
Tilray reports $1.27 billion loss in Q4 2025 as company focuses on Canadian adult use and international markets - StratCann
Tilray Brands: Navigating Global Cannabis Expansion and Strategic Realignment to Meet 2026 EBITDA Goals - AInvest
Tilray outlines $62M-$72M adjusted EBITDA guidance for 2026 amid international cannabis surge and beverage business reset - MSN
Tilray Brands' Q4 2025: Unpacking Contradictions in International Strategy, Cost Savings, and Supply Chain Challenges - AInvest
Tilray's Strategic Turnaround and Path to Profitability in a Shifting Cannabis Market - AInvest
Tilray Q4 Results Show Major Problems (NASDAQ:TLRY) - Seeking Alpha
Earnings call transcript: Tilray Q4 2025 sees revenue miss, stock edges up By Investing.com - Investing.com South Africa
Earnings call transcript: Tilray Q4 2025 sees revenue miss, stock edges up - Investing.com
Tilray Brands, Inc. (TLRY) Q4 Earnings Beat Estimates - Yahoo Finance
Tilray Brands Fiscal Q4 Adjusted Earnings, Revenue Decline - MarketScreener
Tilray Brands in charts: Segmental revenues see double-digit increase sequentially - Seeking Alpha
Tilray Brands Inc Stock (TLRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tilray Brands Inc Stock (TLRY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Merton Carl A | Chief Financial Officer |
Jul 30 '25 |
Buy |
0.60 |
33,500 |
19,939 |
798,069 |
| SIMON IRWIN D | President and CEO |
Jun 02 '25 |
Option Exercise |
0.41 |
1,178,109 |
483,025 |
4,424,593 |
| Merton Carl A | Chief Financial Officer |
Jun 02 '25 |
Option Exercise |
0.41 |
174,477 |
71,536 |
860,532 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jun 02 '25 |
Option Exercise |
0.41 |
249,353 |
102,235 |
785,046 |
| Gendel Mitchell | Global General Counsel |
Jun 02 '25 |
Option Exercise |
0.41 |
231,218 |
94,799 |
651,486 |
| Merton Carl A | Chief Financial Officer |
Nov 15 '24 |
Buy |
1.36 |
26,000 |
35,360 |
26,000 |
| Persofsky Renah | Director |
Nov 08 '24 |
Option Exercise |
1.50 |
11,958 |
17,937 |
75,348 |
1.07%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):